Pemazyre (pemigatinib)

pCPA File Number: 22533
Negotiation Status:
Active Negotiation
For the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement and a ECOG performance status of 0 to 2,
Incyte Biosciences Canada Corporation
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable